Petlife Pharmaceuticals, Inc.
PTLF
$0.0001
$0.000.00%
| 02/28/2018 | 11/30/2017 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.48% | -86.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.48% | -86.79% | |||
| Operating Income | 5.48% | 86.79% | |||
| Income Before Tax | 8.49% | 76.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.49% | 76.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.49% | 76.66% | |||
| EBIT | 5.48% | 86.79% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 9.52% | 54.35% | |||
| Normalized Basic EPS | 33.33% | 48.00% | |||
| EPS Diluted | 9.52% | 54.35% | |||
| Normalized Diluted EPS | 33.33% | 48.00% | |||
| Average Basic Shares Outstanding | 0.79% | -49.08% | |||
| Average Diluted Shares Outstanding | 0.79% | -49.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
